Aprea Therapeutics, Inc. Common stock APRE

$0.68 +1.33% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-12 View →
8-K 8-K 2026-08-12 View →
8-K FORM 8-K 2026-07-23 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
4 OWNERSHIP DOCUMENT 2026-06-17 View →
8-K FORM 8-K 2026-06-17 View →
10-Q 10-Q 2026-05-13 View →
8-K 8-K 2026-05-13 View →
DEF 14A DEF 14A 2026-04-30 View →
S-3 S-3 2026-04-22 View →
4 OWNERSHIP DOCUMENT 2026-04-01 View →
4 OWNERSHIP DOCUMENT 2026-04-01 View →
8-K 8-K 2026-04-01 View →
8-K FORM 8-K 2026-03-30 View →
4 OWNERSHIP DOCUMENT 2026-03-16 View →
4 OWNERSHIP DOCUMENT 2026-03-16 View →
10-K 10-K 2026-03-16 View →
8-K 8-K 2026-03-16 View →
S-3 S-3 2026-02-20 View →
8-K FORM 8-K 2026-02-18 View →
4 OWNERSHIP DOCUMENT 2026-02-02 View →
4 OWNERSHIP DOCUMENT 2026-02-02 View →
8-K FORM 8-K 2026-01-29 View →
8-K FORM 8-K 2026-01-23 View →
8-K 8-K 2026-01-09 View →
S-3 S-3 2025-12-19 View →
4 OWNERSHIP DOCUMENT 2025-12-11 View →
4 OWNERSHIP DOCUMENT 2025-12-11 View →
4 OWNERSHIP DOCUMENT 2025-12-11 View →
8-K FORM 8-K 2025-12-09 View →
10-Q 10-Q 2025-11-12 View →
8-K 8-K 2025-11-12 View →
8-K 8-K 2025-10-24 View →
8-K 8-K 2025-10-15 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.68
Market Cap
$8.46 million
52-Week Range
$0.55 – $2.22
Average Volume
50K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.